Existing studies have demonstrated that the NF-κB pathway can regulate lipid metabolism and then affect DSS-induced colitis [34], atherosclerosis [35] and NAFLD [36]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.